Pancreatic cancer is one of the most challenging cancers, but there is hope — and progress. Since 1999, PanCAN has been leading the fight against pancreatic cancer through research, patient support, advocacy and community action. We’re working to accelerate pancreatic cancer research, advance early detection, connect patients to the best care and improve survival. But our work isn’t finished. We won’t stop until pancreatic cancer is caught early, every patient has access to the treatment they deserve, and survival is the expectation — not the exception. It’s going to take all of us. Together, we can change the story of pancreatic cancer. 💜 Visit 🔗 pancan.org to learn more.

“My father was the rock of our family, and we all looked up to him.” When Nadine A.’s father, Eddie, was diagnosed with pancreatic cancer at just 46, her family knew very little about the disease. They found PanCAN while searching for information and support — and Nadine’s connection to the organization has continued ever since, even after her father’s passing. In 2003, she began volunteering in the Miami area, helping connect her community with information and resources about pancreatic cancer. She later stepped away while raising her children, then returned as a #PanCANvolunteer leader about four years ago. Today, she serves as chair of the PanCAN Miami Affiliate. One memory from those early days has stayed with her. When PanCAN sent her a box filled with educational materials and purple items to share in her community, she showed it to her father. “He said, ‘Wow, that’s hope in a box.’” For Nadine, volunteering has become a way to honor her father, give back to her community and show her children the value of helping others. “I feel like I’ve gained more from volunteering than I’ve put in.” Her whole family has been part of the journey — from helping at events when her children were young to having extended family members contribute their time and support. “It’s a very good feeling to work together for a cause that’s so important to us.” Read Nadine’s story and learn more about the impact of volunteering with PanCAN at 🔗 pcan.at/m9mjd5uq.

#PanCANPurpleStride 2027 is happening Saturday, April 24, and we want our Team Captains back — and looking good! 💜 Register as a Team Captain, raise $50+ toward your personal fundraising goal by Friday, October 9, and you’ll earn a limited-edition Team Captain hat, perfect for wearing at PurpleStride! Visit 🔗 purplestride.org to register today!

Happy first day of fall, PanCAN community. 💜

Seventeen years ago today, the world lost the extraordinary actor, dancer and singer-songwriter Patrick Swayze to pancreatic cancer. He was 57. His legacy lives on through the love and advocacy of his wife, PanCAN Ambassador Lisa Niemi Swayze, who shares: "When Patrick was diagnosed, the statistics were grim. Median survival: three to six months. Five-year survival: nine percent. Startling information, huh? It was beyond depressing. But every ounce of energy we had was gonna go into helping him live. When he first found out he had pancreatic cancer, he turned to me and said, ‘I’m a dead man.’ But soon after, on a walk at our New Mexico ranch, he held my hand and said, ‘I want to live.’ That’s who Patrick was. I made a decision that I was going to be who he needed me to be. I could cry, I could fall apart, I could panic — later. But not now. Cancer doesn’t happen to just one person. It sets out to kill those who love that person a little bit, too. Patrick really was a hero. You give him a sword, a cape and a horse, and he’s a happy man — and when it came to fighting his illness, you really saw his courage. While pancreatic cancer may have taken him in the end, it never beat him. Just because he’s gone doesn’t mean this fight is over. I will continue it for him." Join us in the comments to share our love with Lisa today as we remember Patrick and come together to change the story of pancreatic cancer in his honor. 💜

RASONQUE™ (daraxonrasib) has been approved by the U.S. Food and Drug Administration for the treatment of adults with metastatic pancreatic adenocarcinoma who have received at least one prior systemic therapy or are not candidates for multiagent systemic therapy. 💊 In the latest episode of PancChat, host @AlisynCamerota is joined by Dr. Brian Wolpin of @DanaFarber Cancer Institute to break down what the approval means for patients, how RASONQUE works, who may be eligible, side effects and what’s next for RAS-targeted therapies. Visit 🔗 pcan.at/PancChat to listen. The PancChat podcast is a collaboration between @LetsWinPC and PanCAN, and this episode is sponsored by @RevMedicines.

A Tribute Page is a meaningful way for friends and family to honor, remember and celebrate the life of your loved one. On this page, you can share their story and your memories, while raising money to fund #pancreaticcancer research and patient programs. 💜 Create your lasting memory in three easy steps at 🔗 pcan.at/Tribute.

Last week, The U.S. Food and Drug Administration granted approval for a new drug targeting the mutations that drive more than 90% of pancreatic cancer cases — a sweeping advance for a disease that has few treatment options and a five-year survival rate of just 13%. Share with the PanCAN community in the comments: what does the approval of RASONQUE™ (daraxonrasib) mean to you? 💊

Pain from pancreatic cancer can result from both the disease itself and its treatments. Patients may experience multiple types of pain simultaneously, depending on the cancer's location, stage and treatment approach. Visit 🔗 pcan.at/pain for resources on understanding pancreatic cancer pain, talking with your doctor about pain, supportive care, pain medicines, medical procedures and other approaches to help manage pain.

On National Grief Awareness Day, we’re holding space for everyone navigating the loss of someone they love. You are not alone. 💜

On September 15, PanCAN Chief Scientific & Medical Officer @ABerkenblit, MD, MMSc, will host a live event as part of our new series, PanCAN’s Right Track Live. This first conversation of the series will bring together leading experts in #pancreaticcancer care and research, along with a member of PanCAN Patient Services, to explore: 💊 Groundbreaking treatment news in pancreatic cancer care, including new advancements in treatment that promise to help people living with pancreatic cancer live longer and feel better. 🧬 The basics of biomarkers, and how testing can help patients unlock access to targeted therapies and clinical trials studying specific mutations. 💜 How Patient Services can support patients and their loved ones navigate the road ahead, with educational resources, access to biomarker testing for those who need it and personalized clinical trial searches. Save your virtual seat at 🔗 pcan.at/RightTrackLive.

PanCAN is at the center of a vibrant, diverse community that has been the catalyst for every moment of extraordinary progress realized for this disease. 💜

Bailey Taylor Brown knows firsthand how pancreatic cancer can change a family forever. After losing her father, NBA referee Tony Brown, Bailey chose to turn her loss into purpose by helping raise awareness and support for others facing this disease. 💜 Thanks to a generous Challenge Gift, any gift you give during Drive to Thrive can go THREE TIMES as far to help fuel breakthrough research, connect people with pancreatic cancer to lifesaving care and strengthen the field to move progress forward. Join Bailey, give now and triple your impact at 🔗 pancan.org/DriveToThrive2026.

Category: Champions for Change Answer: This ESPN @Jeopardy! finalist played on behalf of PanCAN, helping secure a $100,000 charitable donation to advance pancreatic cancer research and provide free personalized patient services. Question: Who is @KyleBrandt? We're incredibly grateful to Kyle for choosing PanCAN as his charity and for being a longtime supporter of our mission. Playing in honor of his own family impacted by pancreatic cancer, Kyle is raising awareness for everyone affected by this disease. A special thank you to his brother, #PanCANvolunteer Austin G., whose dedication to our community helped inspire PanCAN as Kyle's charity of choice. We'd also like to recognize Kyle's @GMFB colleague, @JamieErdahl, whose father passed away from pancreatic cancer earlier this year. Together, they're helping move us closer to a world where every patient thrives — making survival the expectation, not the exception. Don't miss Kyle's incredible run on #ESPNJeopardy!, now streaming on @DisneyPlus, @Hulu and the @ESPN app. Join us in the comments to thank Kyle for supporting the pancreatic cancer community. 💜

Planning for the future is one of the most meaningful gifts you can give your loved ones. 💜 During National Make-A-Will Month this August, we're proud to partner with FreeWill to offer a free, easy-to-use estate planning tool that helps you create your will and other essential documents at no cost. If you choose, you can also include PanCAN in your estate plans to help fuel groundbreaking research, support patients and families and create a better future for everyone affected by #pancreaticcancer. Your future, and your legacy, can make a lasting difference. Start planning today at 🔗 pancan.org/yourlegacy.

A pancreatic cancer diagnosis is overwhelming. Patients don’t have time to waste, yet too often they face a maze of disconnected systems, delayed answers and missed opportunities. PanCAN’s one-of-a-kind Patient Services program ensures that no patient walks this journey alone. 💜

Federal investment in research has helped drive meaningful progress against pancreatic cancer. PanCAN is speaking out in response to the Office of Management and Budget's (OMB) proposed rule to overhaul the federal grantmaking system because protecting research is essential to advancing better outcomes for patients. If finalized, the proposal could significantly change how federal research grants are reviewed and awarded, disrupting the peer-reviewed, merit-based system through increased red tape that has helped drive scientific innovation and lifesaving breakthroughs. On behalf of the #pancreaticcancer community, PanCAN submitted official comments to OMB outlining the proposal's potential impact on pancreatic cancer research and patients, joined @OVACinfo's public statement raising concerns about the proposed changes and signed onto the Deadliest Cancers Coalition's comments urging OMB to preserve scientific flexibility, foster innovation and support research. @JulieFleshman, PanCAN President and CEO, shares, “Advances in pancreatic cancer research would not have been possible without the peer-review merit-based grantmaking system used for decades by the National Institutes of Health (NIH) and the Department of Defense (DoD). Thanks to sustained federal funding and a grant review process baked in scientific merit, we are finally seeing progress for the third leading cause of cancer-related death in the U.S. We respectfully request the administration to withdraw this proposed rule, and we stand willing to work with OMB and federal agencies to strengthen the federal research enterprise and continue to make breakthroughs to save patients' lives." Progress against pancreatic cancer is possible when we invest in the science, innovation and collaboration needed to transform the future for patients and families. PanCAN will continue advocating for policies that protect federal research funding and accelerate breakthroughs. 💜

This National Parents' Day, we honor the parents whose love, guidance and legacy continue to inspire action. 💜 For #PanCANvolunteer and advocate Monica M., honoring her parents means carrying their memory forward through advocacy after losing both of them to pancreatic cancer. Looking back on her journey, Monica shared, "Back then, my advocacy was fueled by raw, overwhelming grief. Today, it comes from a quiet, steady purpose." That purpose is deeply rooted in the love she has for her parents and the impact they had on her life. "If you never met my Maa, imagine someone with a warm heart, a sharp mind and zero patience for excuses. She was a loving disciplinarian who gave us strong roots and high expectations. At the same time, she was the anchor of our home and the person who first taught me to read and write, instilling a lifelong love of literature in me. My dad carried that same principled discipline, but his passion was science. A devoted Trekkie, he was fascinated by discovery, logic and the universe. While Maa taught me how to feel and imagine through stories, my dad taught me how to think, question and explore through science." Today, Monica says her advocacy is about more than remembering how her parents died. "It’s no longer a reaction to their passing on, it’s a way to carry their legacy forward." To everyone celebrating a parent, remembering one or missing one today, we're holding you close. Thank you to community members like Monica who continue to turn love into action and help create hope for families facing #pancreaticcancer. Read Monica's story at 🔗 pancan.org/news/a-volunteer-….

As we enter a new era of progress against #pancreaticcancer, we're proud to welcome three exceptional leaders whose expertise will help shape the future of our mission. 💜 Effective today, Peter Bernstein has joined our Board of Directors, and Scott Paulson, MD, and Brian M. Wolpin, MD, MPH, have joined our Scientific and Medical Advisory Board (SMAB). Their leadership comes at a pivotal moment. Building on decades of research and advocacy, we're seeing unprecedented momentum in pancreatic cancer research — and through our All Together We Can campaign, we're working to accelerate breakthroughs, expand patient services and move closer to the survival rates patients deserve. PanCAN President and CEO, @JulieFleshman, shares, "We are proud to welcome these new members to PanCAN. They are joining us at an incredibly exciting time as we are finally at a turning point and poised to reap the benefits of decades of investment, advocacy and research into this challenging disease. Their expertise and commitment are critical as we enter this new era in treatments and strengthen our ability to change the trajectory of pancreatic cancer." Please join us in welcoming Peter, Dr. Paulson and Dr. Wolpin. Read more at 🔗 pcan.at/jt764nsw.

Together, we will demand more, do more, deliver more, for every individual touched by this disease today and all those who will face it tomorrow. 💜 Learn more about the bold goals we've set to accelerate progress by 2030 for all patients with #pancreaticcancer at 🔗 pancan.org/about-us/5-year-a….